Comanche Biopharma Announces European Medicines Agency (EMA) Has Granted Orphan Drug Designation for CBP-4888 in sFlt1-mediated Preterm Preeclampsia
Link to full press release
Search for Articles
Apr 8, 2025
Apr 8, 2025
Puzzle Medical Devices is Thrilled to Announce the Closing of its CAN$43 Million Round to Complete its Clinical Study Led by KF Matheson and Desjardins Capital
Link to full press release
Jan 8, 2025
Experienced Industry Leader Dr. Joerg Moeller Appointed as Chief Executive Officer of Antag Therapeutics
Link to full press release.
Jan 7, 2025
Novel Heart Failure Technology from Alleviant Medical Gains FDA Approval for New Pivotal Trial and Breakthrough Designation for Significant Patient Population
Link to full press release
Dec 11, 2024
RapidPulse Receives FDA Approval to Begin IDE Study in Ischemic Stroke Using Innovative Cyclic Aspiration System – Recently Completed Clinical Trial Shows Significantly Higher First Pass and Frontline Success Rates
Link to full press release